Patents by Inventor Rod Lawson Hartwig

Rod Lawson Hartwig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
    Publication number: 20040142023
    Abstract: The invention relates to compositions and methods for making a transdermal drug delivery system capable of achieving substantially zero-order kinetics for delivery of the active agent over a period of time in excess of 24 hours and at least 72 hours, comprising a pharmaceutically acceptable active agent carrier and a rosin ester which provides a crystal inhibiting and drug stabilizing effect on the active agents incorporated therein.
    Type: Application
    Filed: January 2, 2004
    Publication date: July 22, 2004
    Applicant: NOVEN PHARMACEUTICALS, INC.
    Inventor: Rod Lawson Hartwig
  • Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
    Publication number: 20030152616
    Abstract: The invention relates to compositions and methods for making a transdermal drug delivery system capable of achieving substantially zero-order kinetics for delivery of the active agent over a period of time in excess of 24 hours and at least 72 hours, comprising a pharmaceutically acceptable active agent carrier and a rosin ester which provides a crystal inhibiting and drug stabilizing effect on the active agents incorporated therein.
    Type: Application
    Filed: January 29, 2003
    Publication date: August 14, 2003
    Applicant: NOVEN PHARMACEUTICALS, INC.
    Inventor: Rod Lawson Hartwig
  • Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
    Publication number: 20020106402
    Abstract: The invention relates to compositions and methods for making a transdermal drug delivery system capable of achieving substantially zero-order kinetics for delivery of the active agent over a period of time in excess of 24 hours and at least 72 hours, comprising a pharmaceutically acceptable active agent carrier and a rosin ester which provides a crystal inhibiting and drug stabilizing effect on the active agents incorporated therein.
    Type: Application
    Filed: December 5, 2001
    Publication date: August 8, 2002
    Inventor: Rod Lawson Hartwig